Elite Pharmaceuticals (ELTP) Interest Paid (2009 - 2026)
Elite Pharmaceuticals (ELTP) reported Interest Paid of $54,517 for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$30,006 a year earlier and up 100.7% from the prior quarter.
Elite Pharmaceuticals (ELTP) Interest Paid (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Elite Pharmaceuticals' Interest Paid came in at $198,885, down 54.2% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $246,118, down 63.4% from FY2025.
- Interest Paid has a five-year compound annual growth rate of 6.9% (FY2021 to FY2026).
- By fiscal year, Interest Paid came in at $672,409 in FY2025 (+463.1%), $119,412 in FY2024 (-89.1%), $1.1 million in FY2023 (+518.4%) and $177,636 in FY2022 (+0.8%).
- Five-year quarterly Interest Paid spans a low of -$30,006 in fiscal Q2 2026 and a high of $322,681 in fiscal Q3 2023.
- The high point for year-over-year Interest Paid in five years was fiscal Q3 2023 (growth of 762.8%); the low point was fiscal Q1 2027 (a decline of 82.9%).
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $27,170 (Q1 2027), $89,727 (Q4 2026) and $27,471 (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Paid (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | - |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | - |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | -1.78 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 283.00 Mn |
| 10 | Elite Pharmaceuticals | 401.23 Mn | 274.64 Mn | 15.99 Mn | 54,517.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 54,517.00 |
| Jun 30, 2026 | 27,170.00 |
| Mar 31, 2026 | 89,727.00 |
| Dec 31, 2025 | 27,471.00 |
| Sep 30, 2025 | -30,006.00 |
| Jun 30, 2025 | 158,926.00 |
| Mar 31, 2025 | 168,816.00 |
| Dec 31, 2024 | 136,458.00 |
| Sep 30, 2024 | 144,165.00 |
| Jun 30, 2024 | 222,970.00 |
| Jun 30, 2023 | 119,412.00 |
| Mar 31, 2023 | 316,316.00 |
| Dec 31, 2022 | 322,681.00 |
| Sep 30, 2022 | 242,753.00 |
| Jun 30, 2022 | 216,787.00 |
| Mar 31, 2022 | 51,260.00 |
| Dec 31, 2021 | 37,400.00 |
| Sep 30, 2021 | 74,933.00 |
| Jun 30, 2021 | 14,043.00 |
| Mar 31, 2021 | -63,761.00 |
Elite Pharmaceuticals Interest Paid API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-paid&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-paid", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-paid&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();